These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17884627)

  • 1. Combinatorial enzymatic synthesis of heparan sulfate.
    Linhardt RJ; Kim JH
    Chem Biol; 2007 Sep; 14(9):972-3. PubMed ID: 17884627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.
    Chen J; Jones CL; Liu J
    Chem Biol; 2007 Sep; 14(9):986-93. PubMed ID: 17884631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic placement of 6-O-sulfo groups in heparan sulfate.
    Liu R; Liu J
    Biochemistry; 2011 May; 50(20):4382-91. PubMed ID: 21506605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic synthesis of heparan sulfate and heparin.
    Joice A; Raman K; Mencio C; Quintero MV; Brown S; Nguyen TK; Kuberan B
    Methods Mol Biol; 2015; 1229():11-9. PubMed ID: 25325939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of heparan sulfate-like polysaccharide and application in stem cell chondrogenic differentiation.
    Zhao S; Wang Z; Chen J; Chen J
    Carbohydr Res; 2015 Jan; 401():32-8. PubMed ID: 25464079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III.
    Hernaiz M; Liu J; Rosenberg RD; Linhardt RJ
    Biochem Biophys Res Commun; 2000 Sep; 276(1):292-7. PubMed ID: 11006120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells].
    Nishinaga M; Shimada K
    Rinsho Byori; 1994 Apr; 42(4):340-5. PubMed ID: 8176841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection.
    Born J; Jann K; Assmann KJ; Lindahl U; Berden JH
    J Biol Chem; 1996 Sep; 271(37):22802-9. PubMed ID: 8798457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity of heparanases from human hepatoma and platelets.
    Pikas DS; Li JP; Vlodavsky I; Lindahl U
    J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides.
    Kuberan B; Beeler DL; Lech M; Wu ZL; Rosenberg RD
    J Biol Chem; 2003 Dec; 278(52):52613-21. PubMed ID: 14519763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Synthesis of Heparan Sulfate Oligosaccharides.
    Dulaney SB; Xu Y; Wang P; Tiruchinapally G; Wang Z; Kathawa J; El-Dakdouki MH; Yang B; Liu J; Huang X
    J Org Chem; 2015 Dec; 80(24):12265-79. PubMed ID: 26574650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy for defining critical functional groups on heparan sulfate.
    Wu ZL; Zhang L; Beeler DL; Kuberan B; Rosenberg RD
    FASEB J; 2002 Apr; 16(6):539-45. PubMed ID: 11919156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.
    Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP
    Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.
    Li P; Sheng J; Liu Y; Li J; Liu J; Wang F
    Med Res Rev; 2013 May; 33(3):665-92. PubMed ID: 22495734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).
    Raghuraman A; Mosier PD; Desai UR
    J Med Chem; 2006 Jun; 49(12):3553-62. PubMed ID: 16759098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach.
    Xu Y; Wang Z; Liu R; Bridges AS; Huang X; Liu J
    Glycobiology; 2012 Jan; 22(1):96-106. PubMed ID: 21835782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3-
    Chopra P; Joshi A; Wu J; Lu W; Yadavalli T; Wolfert MA; Shukla D; Zaia J; Boons GJ
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of glycosaminoglycan production and antithrombin III binding by cultured aortic endothelial cells treated with 4-methylumbelliferyl-beta-D-xyloside.
    Shimada K; Ozawa T
    Arteriosclerosis; 1987; 7(6):627-36. PubMed ID: 3689206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of size-defined heparosan, heparan sulfate, and heparin oligosaccharides by enzymatic depolymerization.
    Brown S; Kuberan B
    Methods Mol Biol; 2015; 1229():21-9. PubMed ID: 25325940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.
    Nishinaga M; Ozawa T; Shimada K
    J Clin Invest; 1993 Sep; 92(3):1381-6. PubMed ID: 8376590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.